Rocket Lab shares barely moved Wednesday despite landing a major Pentagon contract. The stock popped 5% at the open, touched $78.38, then gave back everything to close near flat around $74.50. A $397 million Space Force award should move the needle. It didn't. That tells you what Wall Street is really watching.
The Pentagon deal itself is substantial. The U.S. Space Force picked Rocket Lab to build, deploy, and operate satellites for tracking airborne targets, plus supply launch services using the company's still-in-development Neutron rocket. On paper, this is exactly what Rocket Lab pitched: becoming a fully integrated space and defense provider, not just a launch vendor.
The Math Doesn't Impress
Here's the problem. The $397 million contract is nearly twice Rocket Lab's first-quarter revenue and represents meaningful backlog. But it amounts to less than 1% of the company's current market capitalization. Unless the deal prints fat margins or spawns follow-on orders, it won't move the stock much. Investors already priced in that Rocket Lab would win big Pentagon contracts. They're past headline numbers.
Neutron Is Everything Now
What actually matters is execution. The contract bundles three pieces of Rocket Lab's business: satellite manufacturing, launch services, and mission operations. The company will build a series of Flatellites with sensors and low-latency communications, launch them on Neutron, then provide operational support and data handling. That's not a launch contract. It's a full-stack defense program with fixed prices and operational risk.
Neutron hasn't flown yet. The rocket is still in development. If Rocket Lab struggles with Neutron's schedule or runs into margins issues on fixed-price work, this award becomes a liability, not a win. Wall Street's muted reaction suggests analysts are betting on execution, not headlines. The Street remains broadly bullish on the stock, but only if Neutron launches on time and the satellite programs deliver returns. That's the real test ahead.
This article is for informational purposes only and does not constitute investment advice. Always do your own research before making investment decisions.
